| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histidine-tRNA ligase activity | 5.90e-06 | 2 | 49 | 2 | GO:0004821 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.07e-05 | 119 | 49 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | symporter activity | 3.27e-05 | 150 | 49 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 5.38e-05 | 30 | 49 | 3 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 5.38e-05 | 30 | 49 | 3 | GO:0097472 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 2.10e-04 | 9 | 49 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 2.50e-04 | 363 | 49 | 6 | GO:0106310 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 2.62e-04 | 10 | 49 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 3.83e-04 | 12 | 49 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | protein kinase activity | 6.13e-04 | 600 | 49 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 7.45e-04 | 446 | 49 | 6 | GO:0004674 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 7.74e-04 | 296 | 49 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 8.34e-04 | 301 | 49 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.05e-03 | 477 | 49 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | protein kinase binding | 1.19e-03 | 873 | 49 | 8 | GO:0019901 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat modifying activity | 1.44e-03 | 23 | 49 | 2 | GO:0140994 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.44e-03 | 23 | 49 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 1.62e-03 | 709 | 49 | 7 | GO:0016773 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 1.71e-03 | 25 | 49 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.85e-03 | 26 | 49 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 1.87e-03 | 938 | 49 | 8 | GO:0016772 | |
| GeneOntologyMolecularFunction | histone kinase activity | 2.14e-03 | 28 | 49 | 2 | GO:0035173 | |
| GeneOntologyMolecularFunction | kinase binding | 2.29e-03 | 969 | 49 | 8 | GO:0019900 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 2.30e-03 | 29 | 49 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | kinase activity | 2.47e-03 | 764 | 49 | 7 | GO:0016301 | |
| GeneOntologyMolecularFunction | cyclin binding | 3.33e-03 | 35 | 49 | 2 | GO:0030332 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.58e-03 | 125 | 49 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 4.55e-03 | 41 | 49 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 4.77e-03 | 42 | 49 | 2 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 4.77e-03 | 42 | 49 | 2 | GO:0004812 | |
| GeneOntologyBiologicalProcess | histidyl-tRNA aminoacylation | 5.53e-06 | 2 | 49 | 2 | GO:0006427 | |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 3.31e-05 | 4 | 49 | 2 | GO:0140157 | |
| HumanPheno | Abnormal tricuspid chordae tendinae morphology | 1.46e-05 | 2 | 20 | 2 | HP:0031442 | |
| HumanPheno | Short chordae tendineae of the tricuspid valve | 1.46e-05 | 2 | 20 | 2 | HP:0006692 | |
| HumanPheno | Short chordae tendineae of the mitral valve | 1.46e-05 | 2 | 20 | 2 | HP:0011580 | |
| HumanPheno | Abnormal morphology of the chordae tendinae of the mitral valve | 8.75e-05 | 4 | 20 | 2 | HP:0025523 | |
| Domain | His-tRNA-ligase | 6.47e-06 | 2 | 48 | 2 | IPR015807 | |
| Domain | KCC1 | 6.47e-06 | 2 | 48 | 2 | IPR000622 | |
| Domain | HisRS_anticodon | 6.47e-06 | 2 | 48 | 2 | IPR033656 | |
| Domain | HisRS/HisZ | 6.47e-06 | 2 | 48 | 2 | IPR004516 | |
| Domain | KCL_cotranspt | 3.87e-05 | 4 | 48 | 2 | IPR000076 | |
| Domain | Kinase-like_dom | 6.48e-05 | 542 | 48 | 8 | IPR011009 | |
| Domain | SLC12A_fam | 1.35e-04 | 7 | 48 | 2 | IPR004842 | |
| Domain | SLC12_C | 1.79e-04 | 8 | 48 | 2 | IPR018491 | |
| Domain | SLC12 | 1.79e-04 | 8 | 48 | 2 | PF03522 | |
| Domain | HGTP_anticodon | 2.30e-04 | 9 | 48 | 2 | PF03129 | |
| Domain | aa-tRNA-synt_IIb | 3.51e-04 | 11 | 48 | 2 | IPR002314 | |
| Domain | tRNA-synt_2b | 3.51e-04 | 11 | 48 | 2 | PF00587 | |
| Domain | - | 3.51e-04 | 11 | 48 | 2 | 3.40.50.800 | |
| Domain | Anticodon-bd | 5.77e-04 | 14 | 48 | 2 | IPR004154 | |
| Domain | aa-tRNA-synth_II | 9.64e-04 | 18 | 48 | 2 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 9.64e-04 | 18 | 48 | 2 | PS50862 | |
| Domain | PROTEIN_KINASE_ATP | 1.09e-03 | 459 | 48 | 6 | PS00107 | |
| Domain | AA-permease/SLC12A_dom | 1.45e-03 | 22 | 48 | 2 | IPR004841 | |
| Domain | AA_permease | 1.45e-03 | 22 | 48 | 2 | PF00324 | |
| Domain | Prot_kinase_dom | 1.51e-03 | 489 | 48 | 6 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.57e-03 | 493 | 48 | 6 | PS50011 | |
| Domain | Ser/Thr_kinase_AS | 2.16e-03 | 357 | 48 | 5 | IPR008271 | |
| Domain | S_TKc | 2.22e-03 | 359 | 48 | 5 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 2.30e-03 | 362 | 48 | 5 | PS00108 | |
| Domain | Protein_kinase_ATP_BS | 2.80e-03 | 379 | 48 | 5 | IPR017441 | |
| Domain | Pkinase | 2.87e-03 | 381 | 48 | 5 | PF00069 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES | 2.24e-05 | 62 | 38 | 4 | M27618 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.47e-04 | 7 | 38 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.47e-04 | 7 | 38 | 2 | MM15081 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.97e-04 | 108 | 38 | 4 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.04e-04 | 109 | 38 | 4 | MM15074 | |
| Pathway | BIOCARTA_CDC25_PATHWAY | 2.52e-04 | 9 | 38 | 2 | M22031 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M | 2.52e-04 | 9 | 38 | 2 | M47586 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES | 2.70e-04 | 47 | 38 | 3 | MM15328 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 2.79e-04 | 1022 | 38 | 10 | MM15436 | |
| Pathway | BIOCARTA_SRCRPTP_PATHWAY | 3.14e-04 | 10 | 38 | 2 | MM1341 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M | 3.14e-04 | 10 | 38 | 2 | M47572 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 3.68e-04 | 360 | 38 | 6 | M27267 | |
| Pathway | BIOCARTA_SRCRPTP_PATHWAY | 3.83e-04 | 11 | 38 | 2 | M10994 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.83e-04 | 681 | 38 | 8 | MM14985 | |
| Pathway | PID_PDGFRB_PATHWAY | 3.88e-04 | 129 | 38 | 4 | M186 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 4.19e-04 | 238 | 38 | 5 | MM15076 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 4.78e-04 | 57 | 38 | 3 | MM15298 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 5.03e-04 | 58 | 38 | 3 | M805 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 5.15e-04 | 249 | 38 | 5 | M5988 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 5.29e-04 | 59 | 38 | 3 | MM14504 | |
| Pathway | BIOCARTA_RB_PATHWAY | 5.42e-04 | 13 | 38 | 2 | M18159 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 5.73e-04 | 143 | 38 | 4 | MM15383 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 6.43e-04 | 736 | 38 | 8 | M27287 | |
| Pathway | WP_P53_SIGNALING | 7.03e-04 | 65 | 38 | 3 | MM15852 | |
| Pathway | KEGG_P53_SIGNALING_PATHWAY | 8.03e-04 | 68 | 38 | 3 | M6370 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 8.73e-04 | 70 | 38 | 3 | MM15597 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 8.73e-04 | 160 | 38 | 4 | MM15990 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 9.48e-04 | 72 | 38 | 3 | MM15381 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 1.02e-03 | 167 | 38 | 4 | M19381 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 1.03e-03 | 74 | 38 | 3 | M41807 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST | 1.05e-03 | 18 | 38 | 2 | M27633 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 1.20e-03 | 78 | 38 | 3 | M27589 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 1.26e-03 | 304 | 38 | 5 | MM14960 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 1.33e-03 | 81 | 38 | 3 | M865 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 1.33e-03 | 81 | 38 | 3 | M39490 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 1.43e-03 | 83 | 38 | 3 | MM15314 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 1.73e-03 | 23 | 38 | 2 | M47537 | |
| Pathway | BIOCARTA_G2_PATHWAY | 1.88e-03 | 24 | 38 | 2 | M8560 | |
| Pathway | WP_FOCAL_ADHESION | 1.95e-03 | 199 | 38 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.95e-03 | 199 | 38 | 4 | M7253 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 2.05e-03 | 94 | 38 | 3 | M1080 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ARHGDIA FLNA LRPPRC SF3B1 PPP5C DNAH10 HNRNPUL2 ABCD3 CPSF1 PRMT1 CDK1 ATM CDC73 HARS1 SSRP1 HSPA4 | 5.41e-11 | 1425 | 49 | 16 | 30948266 |
| Pubmed | GGH ARHGDIA FLNA LRPPRC SF3B1 HNRNPUL2 RPS6KA3 PSMB6 ABCD3 PRMT1 CDK1 ATM SSRP1 HSPA4 | 7.08e-09 | 1440 | 49 | 14 | 30833792 | |
| Pubmed | ARHGDIA SF3B1 HNRNPUL2 CDK13 POLR2H PSMB6 CPSF1 PRMT1 CDK1 ATM CDC73 SSRP1 | 1.21e-08 | 1014 | 49 | 12 | 32416067 | |
| Pubmed | 2.03e-08 | 122 | 49 | 6 | 36929488 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ARHGDIA FLNA LRPPRC SF3B1 HNRNPUL2 POLR2H PSMB6 ABCD3 CPSF1 PRMT1 CDK1 SSRP1 HSPA4 | 3.14e-08 | 1353 | 49 | 13 | 29467282 |
| Pubmed | 4.61e-08 | 708 | 49 | 10 | 39231216 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNA LRPPRC SF3B1 CDK13 POLR2H PSMB6 ABCD3 PRMT1 CDK1 CDC73 ARHGAP35 SSRP1 HSPA4 | 5.30e-08 | 1415 | 49 | 13 | 28515276 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GGH FLNA PPP5C HNRNPUL2 RPS6KA3 POLR2H PSMB6 PRMT1 CDK1 CDC73 HARS1 SSRP1 HSPA4 | 7.33e-08 | 1455 | 49 | 13 | 22863883 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNA LRPPRC PPP5C CSK HNRNPUL2 RPS6KA3 ABCD3 PRMT1 CDK1 CDC73 HSPA4 | 8.65e-08 | 974 | 49 | 11 | 28675297 |
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 23264621 | ||
| Pubmed | ARHGDIA LRPPRC HNRNPUL2 POLR2H PSMB6 ABCD3 PRMT1 CDK1 SSRP1 HSPA4 | 1.22e-07 | 786 | 49 | 10 | 29128334 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GGH ATRN ARHGDIA FLNA THBS1 CSK MINK1 PSMB6 CDK1 ITGA1 SLC1A1 | 1.32e-07 | 1016 | 49 | 11 | 19056867 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ARHGDIA FLNA LRPPRC SF3B1 HNRNPUL2 ABCD3 CPSF1 PRMT1 CDK1 SSRP1 HSPA4 | 1.43e-07 | 1024 | 49 | 11 | 24711643 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FLNA LRPPRC SF3B1 HNRNPUL2 RPS6KA3 POLR2H ABCD3 PRMT1 CDK1 SSRP1 HSPA4 LRIF1 | 2.10e-07 | 1318 | 49 | 12 | 30463901 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | GGH LRPPRC SF3B1 HNRNPUL2 POLR2H ABCD3 CPSF1 PRMT1 ATM ARHGAP35 SSRP1 | 2.48e-07 | 1082 | 49 | 11 | 38697112 |
| Pubmed | 3.37e-07 | 878 | 49 | 10 | 37223481 | ||
| Pubmed | FLNA LRPPRC SF3B1 PPP5C HNRNPUL2 MINK1 PSMB6 ABCD3 PSD3 PRMT1 ARHGAP35 | 4.12e-07 | 1139 | 49 | 11 | 36417873 | |
| Pubmed | FLNA LRPPRC SF3B1 HNRNPUL2 CDK13 PSMB6 PRMT1 CDK1 CDC73 SSRP1 HSPA4 | 4.65e-07 | 1153 | 49 | 11 | 29845934 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 5.24e-07 | 344 | 49 | 7 | 36282215 | |
| Pubmed | 6.90e-07 | 725 | 49 | 9 | 27025967 | ||
| Pubmed | 7.60e-07 | 534 | 49 | 8 | 35032548 | ||
| Pubmed | 9.61e-07 | 551 | 49 | 8 | 34728620 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNA HARS2 LRPPRC THBS1 SF3B1 HNRNPUL2 ABCD3 CPSF1 PRMT1 CDK1 SSRP1 | 1.08e-06 | 1257 | 49 | 11 | 36526897 |
| Pubmed | 1.36e-06 | 397 | 49 | 7 | 21319273 | ||
| Pubmed | 1.63e-06 | 408 | 49 | 7 | 33766124 | ||
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 1.68e-06 | 258 | 49 | 6 | 21081666 | |
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | 1.92e-06 | 418 | 49 | 7 | 32552912 | |
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 1.94e-06 | 2 | 49 | 2 | 34031912 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21464306 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 7755634 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 17510708 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 8406012 | ||
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 1.94e-06 | 2 | 49 | 2 | 31835175 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 1549469 | ||
| Pubmed | ARHGDIA LRPPRC SF3B1 PPP5C POLR2H PSMB6 ABCD3 PRMT1 CDK1 SSRP1 HSPA4 | 1.95e-06 | 1335 | 49 | 11 | 29229926 | |
| Pubmed | 2.36e-06 | 151 | 49 | 5 | 18457437 | ||
| Pubmed | 2.41e-06 | 844 | 49 | 9 | 25963833 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 2.48e-06 | 847 | 49 | 9 | 35235311 | |
| Pubmed | ARHGDIA FLNA HARS2 SF3B1 CDK13 RPS6KA3 PSMB6 CPSF1 PRMT1 HARS1 SSRP1 | 2.52e-06 | 1371 | 49 | 11 | 36244648 | |
| Pubmed | 2.64e-06 | 1103 | 49 | 10 | 34189442 | ||
| Pubmed | 2.85e-06 | 638 | 49 | 8 | 33239621 | ||
| Pubmed | 3.54e-06 | 657 | 49 | 8 | 36180527 | ||
| Pubmed | 3.75e-06 | 463 | 49 | 7 | 34901782 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ARHGDIA FLNA LRPPRC SF3B1 PPP5C PSMB6 CDK1 HARS1 SSRP1 HSPA4 | 3.79e-06 | 1149 | 49 | 10 | 35446349 |
| Pubmed | SLC12A6 ARHGDIA FLNA LRPPRC SF3B1 HNRNPUL2 MINK1 ABCD3 PSD3 ARHGAP35 HSPA4 | 3.80e-06 | 1431 | 49 | 11 | 37142655 | |
| Pubmed | 4.08e-06 | 469 | 49 | 7 | 37314180 | ||
| Pubmed | LRPPRC SF3B1 PPP5C IFT81 MINK1 ABCD3 PSD3 FNDC3A ATM SSRP1 HSPA4 | 5.47e-06 | 1487 | 49 | 11 | 33957083 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 31352162 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 17376776 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 15383005 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 32699135 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 35274823 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 26501274 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20091789 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 11551954 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 15262997 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 30712845 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 37026485 | ||
| Pubmed | K-Cl cotransporter gene expression during human and murine erythroid differentiation. | 5.83e-06 | 3 | 49 | 2 | 21733850 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 6.51e-06 | 714 | 49 | 8 | 28302793 | |
| Pubmed | 7.65e-06 | 730 | 49 | 8 | 34857952 | ||
| Pubmed | FLNA LRPPRC SF3B1 PPP5C POLR2H PSMB6 ABCD3 CPSF1 SSRP1 HSPA4 | 7.78e-06 | 1247 | 49 | 10 | 27684187 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | LRPPRC SF3B1 POLR2H PSMB6 ABCD3 CPSF1 PRMT1 CDK1 SSRP1 HSPA4 | 8.34e-06 | 1257 | 49 | 10 | 37317656 |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 9.29e-06 | 200 | 49 | 5 | 35546148 | |
| Pubmed | 9.67e-06 | 754 | 49 | 8 | 35906200 | ||
| Pubmed | Artemis links ATM to G2/M checkpoint recovery via regulation of Cdk1-cyclin B. | 1.16e-05 | 4 | 49 | 2 | 17242184 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 11853558 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 12637262 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.17e-05 | 774 | 49 | 8 | 15302935 | |
| Pubmed | 1.39e-05 | 1049 | 49 | 9 | 27880917 | ||
| Pubmed | 1.42e-05 | 568 | 49 | 7 | 37774976 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.47e-05 | 220 | 49 | 5 | 35785414 | |
| Pubmed | IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5. | 1.50e-05 | 221 | 49 | 5 | 31950832 | |
| Pubmed | 1.52e-05 | 803 | 49 | 8 | 36517590 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.58e-05 | 807 | 49 | 8 | 22681889 | |
| Pubmed | 1.61e-05 | 809 | 49 | 8 | 32129710 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 10376525 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 17525741 | ||
| Pubmed | Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent. | 1.94e-05 | 5 | 49 | 2 | 21235734 | |
| Pubmed | Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing. | 1.94e-05 | 5 | 49 | 2 | 26575292 | |
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 2.00e-05 | 113 | 49 | 4 | 23403292 | |
| Pubmed | 2.02e-05 | 399 | 49 | 6 | 37536630 | ||
| Pubmed | 2.03e-05 | 601 | 49 | 7 | 33658012 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 2.17e-05 | 607 | 49 | 7 | 39147351 | |
| Pubmed | 2.28e-05 | 241 | 49 | 5 | 23125841 | ||
| Pubmed | 2.66e-05 | 419 | 49 | 6 | 15635413 | ||
| Pubmed | SLC12A6 EFCAB5 FLNA LRPPRC SF3B1 SLC12A4 CDK13 IFT81 ATM SSRP1 | 2.73e-05 | 1442 | 49 | 10 | 35575683 | |
| Pubmed | 2.86e-05 | 634 | 49 | 7 | 34591612 | ||
| Pubmed | Loss of the Greatwall Kinase Weakens the Spindle Assembly Checkpoint. | 2.91e-05 | 6 | 49 | 2 | 27631493 | |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 2.93e-05 | 254 | 49 | 5 | 28431233 | |
| Pubmed | O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. | 2.93e-05 | 254 | 49 | 5 | 36604567 | |
| Pubmed | 3.07e-05 | 641 | 49 | 7 | 36057605 | ||
| Pubmed | 3.36e-05 | 129 | 49 | 4 | 28973437 | ||
| Pubmed | 3.42e-05 | 652 | 49 | 7 | 31180492 | ||
| Pubmed | 3.45e-05 | 653 | 49 | 7 | 33742100 | ||
| Pubmed | 3.45e-05 | 653 | 49 | 7 | 22586326 | ||
| Pubmed | 3.69e-05 | 660 | 49 | 7 | 32780723 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 3.71e-05 | 910 | 49 | 8 | 36736316 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HARS2 LRPPRC HNRNPUL2 CDK13 PSMB6 ABCD3 CPSF1 CCDC25 FNDC3A SSRP1 | 3.73e-05 | 1496 | 49 | 10 | 32877691 |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 3.85e-05 | 269 | 49 | 5 | 30442662 | |
| Interaction | HSP90AA1 interactions | FLNA LRPPRC THBS1 PPP5C CSK HNRNPUL2 CDK13 RPS6KA3 MINK1 CDKL4 PRMT1 FNDC3A CDK1 CDC73 HSPA4 PLCE1 | 2.40e-08 | 1263 | 49 | 16 | int:HSP90AA1 |
| Interaction | BIRC3 interactions | ARHGDIA FLNA LRPPRC SF3B1 PPP5C DNAH10 HNRNPUL2 ABCD3 CPSF1 PRMT1 CDK1 CDC73 HARS1 SSRP1 HSPA4 | 3.51e-07 | 1334 | 49 | 15 | int:BIRC3 |
| Interaction | FEN1 interactions | 4.05e-07 | 193 | 49 | 7 | int:FEN1 | |
| Interaction | COPS5 interactions | GGH ATRN SF3B1 PPP5C CSK HNRNPUL2 RPS6KA3 PSMB6 CPSF1 ATM HARS1 SSRP1 HSPA4 | 1.51e-06 | 1102 | 49 | 13 | int:COPS5 |
| Interaction | PTEN interactions | FLNA LRPPRC SLC36A1 SF3B1 PPP5C CSK POLR2H ABCD3 PSD3 ATM SSRP1 HSPA4 | 1.63e-06 | 929 | 49 | 12 | int:PTEN |
| Interaction | MIR199A1 interactions | 1.84e-06 | 84 | 49 | 5 | int:MIR199A1 | |
| Interaction | MIR18B interactions | 1.95e-06 | 85 | 49 | 5 | int:MIR18B | |
| Interaction | MIR16-2 interactions | 1.95e-06 | 85 | 49 | 5 | int:MIR16-2 | |
| Interaction | MIR29A interactions | 2.19e-06 | 87 | 49 | 5 | int:MIR29A | |
| Interaction | JUP interactions | 2.20e-06 | 485 | 49 | 9 | int:JUP | |
| Interaction | HSP90AB1 interactions | FLNA LRPPRC PPP5C CSK HNRNPUL2 CDK13 RPS6KA3 CDKL4 PRMT1 FNDC3A CDC73 HSPA4 | 2.30e-06 | 960 | 49 | 12 | int:HSP90AB1 |
| Interaction | MIR92A2 interactions | 2.59e-06 | 90 | 49 | 5 | int:MIR92A2 | |
| Interaction | MIR19B2 interactions | 3.21e-06 | 94 | 49 | 5 | int:MIR19B2 | |
| Interaction | AR interactions | FLNA SF3B1 PPP5C HNRNPUL2 POLR2H ABCD3 CPSF1 PRMT1 CDK1 CDC73 SSRP1 HSPA4 | 3.23e-06 | 992 | 49 | 12 | int:AR |
| Interaction | ITGB3 interactions | 3.42e-06 | 170 | 49 | 6 | int:ITGB3 | |
| Interaction | OTUD1 interactions | 3.42e-06 | 170 | 49 | 6 | int:OTUD1 | |
| Interaction | KARS1 interactions | 3.61e-06 | 383 | 49 | 8 | int:KARS1 | |
| Interaction | STIP1 interactions | SLC12A6 FLNA LRPPRC SF3B1 PPP5C CSK RPS6KA3 ABCD3 CDK1 CDC73 SSRP1 HSPA4 | 3.73e-06 | 1006 | 49 | 12 | int:STIP1 |
| Interaction | LGALS8 interactions | 3.91e-06 | 174 | 49 | 6 | int:LGALS8 | |
| Interaction | MIR106B interactions | 3.95e-06 | 98 | 49 | 5 | int:MIR106B | |
| Interaction | MIR19B1 interactions | 5.29e-06 | 104 | 49 | 5 | int:MIR19B1 | |
| Interaction | MIR34A interactions | 5.29e-06 | 104 | 49 | 5 | int:MIR34A | |
| Interaction | CEBPB interactions | GGH ARHGDIA FLNA LRPPRC SF3B1 PPP5C CDK13 RPS6KA3 POLR2H PRMT1 CDC73 HARS1 SSRP1 HSPA4 | 5.46e-06 | 1443 | 49 | 14 | int:CEBPB |
| Interaction | KCNA3 interactions | ARHGDIA LRPPRC CSK MINK1 ABCD3 PSD3 PRMT1 FNDC3A CDK1 SLC1A1 HSPA4 | 5.95e-06 | 871 | 49 | 11 | int:KCNA3 |
| Interaction | FKBP5 interactions | 6.40e-06 | 414 | 49 | 8 | int:FKBP5 | |
| Interaction | MCM2 interactions | GGH FLNA LRPPRC SF3B1 CSK PSMB6 CPSF1 PRMT1 CDK1 ATM HARS1 SSRP1 | 7.78e-06 | 1081 | 49 | 12 | int:MCM2 |
| Interaction | SNW1 interactions | 1.02e-05 | 747 | 49 | 10 | int:SNW1 | |
| Interaction | BARD1 interactions | 1.23e-05 | 323 | 49 | 7 | int:BARD1 | |
| Interaction | WDR82 interactions | 1.24e-05 | 213 | 49 | 6 | int:WDR82 | |
| Interaction | NUDC interactions | 1.61e-05 | 337 | 49 | 7 | int:NUDC | |
| Interaction | TERF1 interactions | 1.95e-05 | 347 | 49 | 7 | int:TERF1 | |
| Interaction | CDC37 interactions | 2.18e-05 | 645 | 49 | 9 | int:CDC37 | |
| Interaction | MIR138-1 interactions | 2.24e-05 | 68 | 49 | 4 | int:MIR138-1 | |
| Interaction | GTF2E1 interactions | 2.57e-05 | 144 | 49 | 5 | int:GTF2E1 | |
| Interaction | SERBP1 interactions | EFCAB5 FLNA HARS2 LRPPRC SF3B1 CSK CDK13 RPS6KA3 PRMT1 FNDC3A CDK1 HARS1 HSPA4 | 2.61e-05 | 1432 | 49 | 13 | int:SERBP1 |
| Interaction | MIR122 interactions | 2.66e-05 | 71 | 49 | 4 | int:MIR122 | |
| Interaction | VCP interactions | GGH ARHGDIA LRPPRC PPP5C CSK HNRNPUL2 PSMB6 PRMT1 FNDC3A CDK1 CDC73 ITGA1 HSPA4 | 2.67e-05 | 1435 | 49 | 13 | int:VCP |
| Interaction | EFTUD2 interactions | FLNA LRPPRC SF3B1 CDK13 POLR2H ABCD3 PRMT1 CDK1 CDC73 HARS1 ARHGAP35 SSRP1 HSPA4 | 2.96e-05 | 1449 | 49 | 13 | int:EFTUD2 |
| Interaction | RHOH interactions | 2.96e-05 | 512 | 49 | 8 | int:RHOH | |
| Interaction | MIR29B1 interactions | 2.97e-05 | 73 | 49 | 4 | int:MIR29B1 | |
| Interaction | MIR15A interactions | 3.30e-05 | 75 | 49 | 4 | int:MIR15A | |
| Interaction | MIR199A2 interactions | 3.48e-05 | 76 | 49 | 4 | int:MIR199A2 | |
| Interaction | CDK9 interactions | 3.49e-05 | 685 | 49 | 9 | int:CDK9 | |
| Interaction | USP19 interactions | 3.55e-05 | 154 | 49 | 5 | int:USP19 | |
| Interaction | TFPI interactions | 3.79e-05 | 27 | 49 | 3 | int:TFPI | |
| Interaction | CDC73 interactions | 3.85e-05 | 386 | 49 | 7 | int:CDC73 | |
| Interaction | MIR92A1 interactions | 3.85e-05 | 78 | 49 | 4 | int:MIR92A1 | |
| Interaction | TOP1 interactions | 3.95e-05 | 696 | 49 | 9 | int:TOP1 | |
| Interaction | MIR206 interactions | 4.05e-05 | 79 | 49 | 4 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 4.05e-05 | 79 | 49 | 4 | int:MIR1-2 | |
| Interaction | PAICS interactions | 4.08e-05 | 263 | 49 | 6 | int:PAICS | |
| Interaction | MIR143 interactions | 4.26e-05 | 80 | 49 | 4 | int:MIR143 | |
| Interaction | PSMC2 interactions | 4.31e-05 | 393 | 49 | 7 | int:PSMC2 | |
| Interaction | MIR145 interactions | 4.47e-05 | 81 | 49 | 4 | int:MIR145 | |
| Interaction | PRPF4 interactions | 4.82e-05 | 271 | 49 | 6 | int:PRPF4 | |
| Interaction | H3C1 interactions | THBS1 SF3B1 HNRNPUL2 CDK13 RPS6KA3 PRMT1 ATM CDC73 SSRP1 LRIF1 | 5.09e-05 | 901 | 49 | 10 | int:H3C1 |
| Interaction | MIR107 interactions | 5.40e-05 | 85 | 49 | 4 | int:MIR107 | |
| Interaction | MIR17 interactions | 5.40e-05 | 85 | 49 | 4 | int:MIR17 | |
| Interaction | MIR9-1 interactions | 5.40e-05 | 85 | 49 | 4 | int:MIR9-1 | |
| Interaction | ZC3H14 interactions | 5.53e-05 | 169 | 49 | 5 | int:ZC3H14 | |
| Interaction | RHOG interactions | SLC12A6 ARHGDIA HARS2 LRPPRC SLC12A4 ABCD3 PSD3 FNDC3A ITGA1 ARHGAP35 | 5.54e-05 | 910 | 49 | 10 | int:RHOG |
| Interaction | MIR20B interactions | 5.66e-05 | 86 | 49 | 4 | int:MIR20B | |
| Interaction | MIR141 interactions | 6.19e-05 | 88 | 49 | 4 | int:MIR141 | |
| Interaction | HDAC6 interactions | 6.59e-05 | 929 | 49 | 10 | int:HDAC6 | |
| Interaction | MIR221 interactions | 6.76e-05 | 90 | 49 | 4 | int:MIR221 | |
| Interaction | RXFP1 interactions | 6.76e-05 | 90 | 49 | 4 | int:RXFP1 | |
| Interaction | TDP1 interactions | 7.00e-05 | 33 | 49 | 3 | int:TDP1 | |
| Interaction | MIR155 interactions | 7.36e-05 | 92 | 49 | 4 | int:MIR155 | |
| Interaction | SUGT1 interactions | 7.42e-05 | 293 | 49 | 6 | int:SUGT1 | |
| Interaction | HDAC5 interactions | 7.82e-05 | 432 | 49 | 7 | int:HDAC5 | |
| Interaction | MIRLET7F1 interactions | 8.01e-05 | 94 | 49 | 4 | int:MIRLET7F1 | |
| Interaction | HSD17B10 interactions | 8.05e-05 | 434 | 49 | 7 | int:HSD17B10 | |
| Interaction | PSMD2 interactions | 8.17e-05 | 435 | 49 | 7 | int:PSMD2 | |
| Interaction | PSMD10 interactions | 8.93e-05 | 187 | 49 | 5 | int:PSMD10 | |
| Interaction | MIRLET7F2 interactions | 9.05e-05 | 97 | 49 | 4 | int:MIRLET7F2 | |
| Interaction | MIR128-2 interactions | 9.80e-05 | 99 | 49 | 4 | int:MIR128-2 | |
| Interaction | HSPH1 interactions | 9.81e-05 | 448 | 49 | 7 | int:HSPH1 | |
| Interaction | NR2C2 interactions | FLNA LRPPRC SF3B1 HNRNPUL2 RPS6KA3 POLR2H ABCD3 PRMT1 CDK1 SSRP1 HSPA4 LRIF1 | 1.02e-04 | 1403 | 49 | 12 | int:NR2C2 |
| Interaction | MIR19A interactions | 1.02e-04 | 100 | 49 | 4 | int:MIR19A | |
| Interaction | MIRLET7A3 interactions | 1.10e-04 | 102 | 49 | 4 | int:MIRLET7A3 | |
| Interaction | MIR15B interactions | 1.14e-04 | 103 | 49 | 4 | int:MIR15B | |
| Interaction | PRMT8 interactions | 1.19e-04 | 104 | 49 | 4 | int:PRMT8 | |
| Interaction | RIN3 interactions | 1.20e-04 | 463 | 49 | 7 | int:RIN3 | |
| Interaction | USP45 interactions | 1.25e-04 | 40 | 49 | 3 | int:USP45 | |
| Interaction | NRN1 interactions | 1.25e-04 | 40 | 49 | 3 | int:NRN1 | |
| Interaction | MIRLET7E interactions | 1.28e-04 | 106 | 49 | 4 | int:MIRLET7E | |
| Interaction | NCAPG interactions | 1.28e-04 | 202 | 49 | 5 | int:NCAPG | |
| Interaction | RUFY1 interactions | 1.43e-04 | 476 | 49 | 7 | int:RUFY1 | |
| Interaction | DDX42 interactions | 1.47e-04 | 208 | 49 | 5 | int:DDX42 | |
| Interaction | MIR34B interactions | 1.47e-04 | 110 | 49 | 4 | int:MIR34B | |
| Interaction | UFL1 interactions | 1.56e-04 | 1031 | 49 | 10 | int:UFL1 | |
| Interaction | CEBPA interactions | ARHGDIA FLNA PPP5C HNRNPUL2 CDK13 PRMT1 CDK1 CDC73 SSRP1 HSPA4 LRIF1 | 1.58e-04 | 1245 | 49 | 11 | int:CEBPA |
| Interaction | OR10S1 interactions | 1.61e-04 | 8 | 49 | 2 | int:OR10S1 | |
| Interaction | BRCA1 interactions | FLNA SF3B1 HNRNPUL2 ABRAXAS1 POLR2H PRMT1 CDK1 ATM CDC73 SSRP1 HSPA4 | 1.63e-04 | 1249 | 49 | 11 | int:BRCA1 |
| Interaction | TERF2 interactions | 1.67e-04 | 340 | 49 | 6 | int:TERF2 | |
| Interaction | MIRLET7I interactions | 1.69e-04 | 114 | 49 | 4 | int:MIRLET7I | |
| Interaction | MDM2 interactions | 1.71e-04 | 658 | 49 | 8 | int:MDM2 | |
| Interaction | CUL7 interactions | 1.74e-04 | 845 | 49 | 9 | int:CUL7 | |
| Interaction | RBBP6 interactions | 1.75e-04 | 216 | 49 | 5 | int:RBBP6 | |
| Interaction | DHX9 interactions | 1.78e-04 | 662 | 49 | 8 | int:DHX9 | |
| Cytoband | 19q13.3 | 9.54e-05 | 82 | 49 | 3 | 19q13.3 | |
| Cytoband | 5q31.3 | 6.87e-04 | 36 | 49 | 2 | 5q31.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q14 | 1.96e-03 | 61 | 49 | 2 | chr15q14 | |
| GeneFamily | Cyclin dependent kinases | 1.68e-05 | 26 | 35 | 3 | 496 | |
| GeneFamily | Solute carriers | 9.94e-05 | 395 | 35 | 6 | 752 | |
| GeneFamily | Dyneins, axonemal | 4.86e-04 | 17 | 35 | 2 | 536 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 6.10e-04 | 19 | 35 | 2 | 132 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN | 1.42e-05 | 165 | 49 | 5 | M6685 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 2.78e-05 | 93 | 49 | 4 | M4752 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN | 3.49e-05 | 199 | 49 | 5 | M7651 | |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP | 3.57e-05 | 200 | 49 | 5 | M5119 | |
| Coexpression | LOPEZ_TRANSLATION_VIA_FN1_SIGNALING | 3.85e-05 | 35 | 49 | 3 | M2426 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | 7.14e-05 | 553 | 49 | 7 | M1475 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.31e-06 | 194 | 49 | 5 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.56e-06 | 198 | 49 | 5 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.69e-06 | 200 | 49 | 5 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-05 | 176 | 49 | 4 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.46e-05 | 179 | 49 | 4 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.46e-05 | 179 | 49 | 4 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-05 | 179 | 49 | 4 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.46e-05 | 179 | 49 | 4 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-05 | 181 | 49 | 4 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 183 | 49 | 4 | 18040d0653286071df959513c63d94b555a5d00a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 183 | 49 | 4 | 6ca7c2d7c56e0f1b9038ba677b4c1c3dfd63bfce | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-05 | 191 | 49 | 4 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 5.74e-05 | 191 | 49 | 4 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-05 | 192 | 49 | 4 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 5.86e-05 | 192 | 49 | 4 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 5.86e-05 | 192 | 49 | 4 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-CTL|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.10e-05 | 194 | 49 | 4 | 6b2bb3dd11fd53fa9ab4d66c18b0714f96f99288 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.10e-05 | 194 | 49 | 4 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 6.22e-05 | 195 | 49 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.35e-05 | 196 | 49 | 4 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|erythropoietic / Lineage and Cell class | 6.73e-05 | 199 | 49 | 4 | 39c4adef3e02f948414f866aa22ac76f44b7b7db | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.86e-05 | 200 | 49 | 4 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | myeloid-pro-cDC|myeloid / Lineage and Cell class | 6.86e-05 | 200 | 49 | 4 | 4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Highly_activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.86e-05 | 200 | 49 | 4 | d92d3bc63a56a604d7b1d49e62d4304e5e4017f2 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.27e-04 | 122 | 49 | 3 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 5.87e-04 | 149 | 49 | 3 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | Nasal_Brush-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.98e-04 | 150 | 49 | 3 | d39d73a1de6a873292d48e469d9403f513045be3 | |
| ToppCell | Nasal_Brush-Epithelial-Club|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.98e-04 | 150 | 49 | 3 | c68645ffcffe524cf1d9736cf72a15b37ed8dc3d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-04 | 152 | 49 | 3 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-04 | 152 | 49 | 3 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-04 | 154 | 49 | 3 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-04 | 154 | 49 | 3 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-04 | 154 | 49 | 3 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-04 | 157 | 49 | 3 | 0ad242320ada7bcb9e29548d3050bf4fd3a07115 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-04 | 157 | 49 | 3 | fe4c9556806203e57522d1986754ebe5a20aa2de | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-04 | 160 | 49 | 3 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 7.34e-04 | 161 | 49 | 3 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.34e-04 | 161 | 49 | 3 | 66554f59eaea4ba55a6c6724f9368e24e99c91e9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.61e-04 | 163 | 49 | 3 | 4be3158f2a0ab460cfea8080a7370922910b5da9 | |
| ToppCell | COVID-CD8-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 8.02e-04 | 166 | 49 | 3 | 4ca8c91b03d08489f244898cf9423b9d10348bc8 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-04 | 167 | 49 | 3 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | Posterior_cortex-Endothelial-MURAL|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.45e-04 | 169 | 49 | 3 | 0ae65daf092396b71f790b65c7a2feed90397417 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 8.45e-04 | 169 | 49 | 3 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.45e-04 | 169 | 49 | 3 | 8cd70ce27b1cecb83f8a376230e7ef41b079b124 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.45e-04 | 169 | 49 | 3 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-04 | 169 | 49 | 3 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-04 | 169 | 49 | 3 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.59e-04 | 170 | 49 | 3 | 65c7ed586e7615203a59999549892ed466a89502 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-04 | 170 | 49 | 3 | 833b4f44ea1fa673dfc6b43ce45a79fe68ae3b05 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 8.74e-04 | 171 | 49 | 3 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.89e-04 | 172 | 49 | 3 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-dnT|Int-URO / Disease, Lineage and Cell Type | 8.89e-04 | 172 | 49 | 3 | e70299573da1679d6d286c3a43699cbff76e207d | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 8.89e-04 | 172 | 49 | 3 | 6b8a8d3b97c10b9d092307eed3cacbd2745df185 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.04e-04 | 173 | 49 | 3 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue | 9.04e-04 | 173 | 49 | 3 | 783b8fa08b9d8f597f251793eae164151662f1f9 | |
| ToppCell | (00)_Basal-(1)_24hpi|(00)_Basal / shred by cell type and Timepoint | 9.04e-04 | 173 | 49 | 3 | a8e62e7d8baf6af691acd5c50deedbadc119ceba | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.04e-04 | 173 | 49 | 3 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.19e-04 | 174 | 49 | 3 | 00cf27bc23af1472a507be31fba6245a8fdd901b | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.19e-04 | 174 | 49 | 3 | b8d1c556290d188f56aeefc17f03119686945fe7 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.19e-04 | 174 | 49 | 3 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.34e-04 | 175 | 49 | 3 | c82ec6deb6ccdd991a69a62b6d62d5b14c803d7a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.34e-04 | 175 | 49 | 3 | b1369d2b74f461e6822d0c33e9b50fe0dfbceb54 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-04 | 177 | 49 | 3 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-04 | 177 | 49 | 3 | ae01c19403a09f7ba5e4beafdfcd1b8eebdadcb7 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-04 | 177 | 49 | 3 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-04 | 177 | 49 | 3 | bd3d07bdef6e903995d4bbfb6ff3a5e1d9fb70cc | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-04 | 177 | 49 | 3 | 35d42b07d9c31528bf59199e361bb8a3bfbe3b75 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 9.81e-04 | 178 | 49 | 3 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-04 | 178 | 49 | 3 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-04 | 178 | 49 | 3 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.97e-04 | 179 | 49 | 3 | 5be883d7d0be3180bb9844e4a757f0dd247294e4 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.97e-04 | 179 | 49 | 3 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.97e-04 | 179 | 49 | 3 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.97e-04 | 179 | 49 | 3 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.97e-04 | 179 | 49 | 3 | 798f208014f2229c597934775646ddbbacf94b69 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-03 | 180 | 49 | 3 | 852e0ea2da58605b059d533dc3fae368709e879a | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-03 | 180 | 49 | 3 | cf6e9f757afeb342c5023f6e6152a1b4d0d164b4 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-03 | 181 | 49 | 3 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-03 | 181 | 49 | 3 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-03 | 181 | 49 | 3 | 6873c1138b28c130637d06b64981ad11c262e85f | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Ciliated|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.03e-03 | 181 | 49 | 3 | 8eed9d46d924b16f6dd1a025ff612244b02b4391 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-03 | 182 | 49 | 3 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-03 | 182 | 49 | 3 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-03 | 182 | 49 | 3 | 975f6275777fc578eba528e50f69891c66ec44ad | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-03 | 183 | 49 | 3 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-03 | 183 | 49 | 3 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-03 | 183 | 49 | 3 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-03 | 183 | 49 | 3 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-03 | 183 | 49 | 3 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-03 | 183 | 49 | 3 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-03 | 184 | 49 | 3 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-03 | 184 | 49 | 3 | 7f8488dbb1ee41372cdbcd34a2e14b377218bf0f | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-03 | 184 | 49 | 3 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 1.08e-03 | 184 | 49 | 3 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-03 | 184 | 49 | 3 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-03 | 184 | 49 | 3 | 2df903924df9cb71039159416bcbe6a6614e21fe | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 185 | 49 | 3 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-03 | 185 | 49 | 3 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.10e-03 | 185 | 49 | 3 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.10e-03 | 185 | 49 | 3 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| Computational | Neighborhood of ATOX1 | 1.25e-04 | 80 | 35 | 4 | MORF_ATOX1 | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.65e-06 | 194 | 49 | 6 | 4281_DN | |
| Drug | Erythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 3.76e-06 | 195 | 49 | 6 | 5329_UP | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 4.23e-06 | 199 | 49 | 6 | 2618_DN | |
| Drug | hexamidine | 8.86e-06 | 19 | 49 | 3 | CID000065130 | |
| Drug | genistein | GGH ARHGDIA THBS1 SLC12A4 CSK RPS6KA3 FNDC3A SLC45A2 CDK1 ITGA1 PLCE1 | 1.97e-05 | 1117 | 49 | 11 | CID005280961 |
| Drug | Coal Ash | 2.32e-05 | 159 | 49 | 5 | ctd:D060729 | |
| Drug | HepIII | 2.64e-05 | 27 | 49 | 3 | CID003036270 | |
| Drug | LY294002 | 2.69e-05 | 748 | 49 | 9 | CID000003973 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 3.07e-05 | 83 | 49 | 4 | CID011968896 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 3.57e-05 | 174 | 49 | 5 | 1651_UP | |
| Drug | AC1O5WLA | 3.65e-05 | 30 | 49 | 3 | CID006442113 | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.04e-05 | 187 | 49 | 5 | 4323_DN | |
| Drug | ATP,Gamma S | 5.30e-05 | 189 | 49 | 5 | CID000002028 | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 5.71e-05 | 192 | 49 | 5 | 3382_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 5.85e-05 | 193 | 49 | 5 | 1464_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 4736_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 2068_UP | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 4318_UP | |
| Drug | 4-hydroxynonenal | 6.28e-05 | 471 | 49 | 7 | CID000001693 | |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 7265_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 6.30e-05 | 196 | 49 | 5 | 5540_DN | |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; HL60; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 1843_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 1641_UP | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 7437_DN | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; PC3; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 1824_DN | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 6228_DN | |
| Drug | Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 7496_UP | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; HL60; HG-U133A | 6.77e-05 | 199 | 49 | 5 | 1763_DN | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 7461_DN | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; HL60; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 1322_UP | |
| Drug | Potassium Chloride | 6.77e-05 | 6 | 49 | 2 | DB00761 | |
| Drug | S-K-E | 9.46e-05 | 7 | 49 | 2 | CID005330790 | |
| Drug | flavopiridol | 9.96e-05 | 216 | 49 | 5 | CID005287969 | |
| Drug | benzo(a)pyrene | 1.15e-04 | 358 | 49 | 6 | CID000002336 | |
| Drug | hellebrigenin | 1.26e-04 | 8 | 49 | 2 | ctd:C001330 | |
| Drug | Chlorine | 1.31e-04 | 367 | 49 | 6 | ctd:D002713 | |
| Drug | anti-BaPDE | 1.45e-04 | 234 | 49 | 5 | CID000041322 | |
| Drug | AC1L1IHP | 1.49e-04 | 728 | 49 | 8 | CID000004584 | |
| Drug | NSC401575 | 1.71e-04 | 129 | 49 | 4 | CID000003165 | |
| Drug | U nu | 1.81e-04 | 51 | 49 | 3 | CID000023943 | |
| Drug | AC1L1ICP | 2.02e-04 | 10 | 49 | 2 | CID000004520 | |
| Drug | ICRF-193 | 2.15e-04 | 54 | 49 | 3 | CID000115150 | |
| Drug | 1m0o | 2.40e-04 | 56 | 49 | 3 | CID006323413 | |
| Drug | DCPIB | 2.46e-04 | 11 | 49 | 2 | CID010071166 | |
| Drug | Busulfan | 2.53e-04 | 57 | 49 | 3 | ctd:D002066 | |
| Drug | liposomal doxorubicin | 2.95e-04 | 12 | 49 | 2 | ctd:C506643 | |
| Drug | camphorquinone | 2.95e-04 | 12 | 49 | 2 | ctd:C553149 | |
| Drug | cyclosulfamuron | 3.73e-04 | 65 | 49 | 3 | CID006451137 | |
| Drug | 8-aminohexylamino-cAMP | 4.06e-04 | 14 | 49 | 2 | CID000001906 | |
| Drug | AD 288 | 4.06e-04 | 14 | 49 | 2 | CID000073553 | |
| Drug | hexa-1,3,5-triene | 4.06e-04 | 14 | 49 | 2 | CID000016695 | |
| Drug | Furosemide | 4.27e-04 | 164 | 49 | 4 | ctd:D005665 | |
| Drug | 1b9v | 4.44e-04 | 69 | 49 | 3 | CID000444508 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 4.47e-04 | 166 | 49 | 4 | 1066_UP | |
| Drug | NSC105327 | 4.63e-04 | 70 | 49 | 3 | CID005318433 | |
| Drug | 8R-HpETE | 4.68e-04 | 15 | 49 | 2 | CID005283170 | |
| Drug | glycine | 4.78e-04 | 169 | 49 | 4 | CID000000750 | |
| Drug | K00051 | 4.83e-04 | 71 | 49 | 3 | CID009549278 | |
| Drug | H-Mn | 4.83e-04 | 71 | 49 | 3 | CID000445522 | |
| Drug | AC1L1DSQ | 5.34e-04 | 16 | 49 | 2 | CID000002491 | |
| Drug | Bumetanide | 5.34e-04 | 16 | 49 | 2 | ctd:D002034 | |
| Drug | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine | 5.34e-04 | 16 | 49 | 2 | ctd:C471843 | |
| Drug | caffeic acid phenethyl ester | 5.37e-04 | 311 | 49 | 5 | ctd:C055494 | |
| Drug | imidazoacridinone | 6.04e-04 | 17 | 49 | 2 | CID000132127 | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 6.32e-04 | 182 | 49 | 4 | 5292_UP | |
| Drug | isocycloheximide | 6.41e-04 | 905 | 49 | 8 | CID000002900 | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 6.58e-04 | 184 | 49 | 4 | 2686_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 6.72e-04 | 185 | 49 | 4 | 4688_DN | |
| Drug | Src family kinase inhibitor PP2 | 6.79e-04 | 18 | 49 | 2 | CID000004878 | |
| Drug | AC1O5PL5 | 6.79e-04 | 18 | 49 | 2 | CID006438380 | |
| Drug | queuine | 6.79e-04 | 18 | 49 | 2 | CID000114881 | |
| Drug | racer | 6.79e-04 | 18 | 49 | 2 | CID000091677 | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 7.00e-04 | 187 | 49 | 4 | 3278_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; HL60; HT_HG-U133A | 7.14e-04 | 188 | 49 | 4 | 1299_UP | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 7.14e-04 | 188 | 49 | 4 | 4545_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 7.28e-04 | 189 | 49 | 4 | 6649_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A | 7.42e-04 | 190 | 49 | 4 | 4582_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 7.42e-04 | 190 | 49 | 4 | 4306_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; PC3; HT_HG-U133A | 7.57e-04 | 191 | 49 | 4 | 4299_DN | |
| Drug | CuSO4.5H2O | 7.58e-04 | 19 | 49 | 2 | CID000024463 | |
| Drug | Grgds | 7.63e-04 | 83 | 49 | 3 | CID000123811 | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 4104_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 5206_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 2766_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Down 200; 11.2uM; HL60; HG-U133A | 7.72e-04 | 192 | 49 | 4 | 1413_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 6223_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 2865_DN | |
| Drug | Tridihexethyl chloride; Down 200; 11.4uM; MCF7; HT_HG-U133A | 7.72e-04 | 192 | 49 | 4 | 3526_DN | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; HL60; HG-U133A | 7.72e-04 | 192 | 49 | 4 | 1419_DN | |
| Drug | NSC618487 | 7.82e-04 | 933 | 49 | 8 | CID000005279 | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 5232_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 2852_UP | |
| Drug | Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 7418_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; MCF7; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 3870_UP | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 4650_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.87e-04 | 193 | 49 | 4 | 5239_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HG-U133A | 7.87e-04 | 193 | 49 | 4 | 1958_DN | |
| Drug | NS-398; Up 200; 10uM; MCF7; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 6897_UP | |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 2087_DN | |
| Drug | Iopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A | 8.02e-04 | 194 | 49 | 4 | 3481_UP | |
| Disease | Usher syndrome type 3B (implicated_via_orthology) | 2.59e-06 | 2 | 48 | 2 | DOID:0110842 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease, axonal type 2W (implicated_via_orthology) | 2.59e-06 | 2 | 48 | 2 | DOID:0110162 (implicated_via_orthology) | |
| Disease | Perrault syndrome (implicated_via_orthology) | 1.55e-05 | 4 | 48 | 2 | DOID:0050857 (implicated_via_orthology) | |
| Disease | sensory peripheral neuropathy (implicated_via_orthology) | 1.55e-05 | 4 | 48 | 2 | DOID:2491 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 5.46e-05 | 45 | 48 | 3 | C0278701 | |
| Disease | lymphocyte count | 1.02e-04 | 1464 | 48 | 10 | EFO_0004587 | |
| Disease | epilepsy (implicated_via_orthology) | 1.44e-04 | 163 | 48 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | retinal vasculature measurement | 1.85e-04 | 517 | 48 | 6 | EFO_0010554 | |
| Disease | Calcium channel blocker use measurement | 4.00e-04 | 213 | 48 | 4 | EFO_0009930 | |
| Disease | serum gamma-glutamyl transferase measurement | 6.50e-04 | 914 | 48 | 7 | EFO_0004532 | |
| Disease | functional brain measurement, language measurement | 9.53e-04 | 28 | 48 | 2 | EFO_0007797, EFO_0007849 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.01e-03 | 713 | 48 | 6 | EFO_0005689 | |
| Disease | esophageal carcinoma | 1.09e-03 | 30 | 48 | 2 | EFO_0002916 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1.09e-03 | 30 | 48 | 2 | C1868672 | |
| Disease | intellectual disability (is_implicated_in) | 1.09e-03 | 30 | 48 | 2 | DOID:1059 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DEEIEKMKGFGEYSR | 391 | Q6UWZ7 | |
| KEETEGFKIDTMGTY | 301 | Q6P1J9 | |
| MEKYEKLAKTGEGSY | 1 | Q5MAI5 | |
| VEEKGGLYIVTEYMA | 256 | P41240 | |
| KEIDYMFLVGTEEGK | 506 | Q9UI46 | |
| YGQVYKARDKDTGEM | 716 | Q14004 | |
| VFYMEDYLTVKTGEE | 316 | Q99873 | |
| VMSEEKNEGELYYKA | 496 | P98198 | |
| GYVDATYREGMTKEE | 171 | P28072 | |
| VEEYVYEMRDKLSGE | 621 | P34932 | |
| SGTYKETEFMVKEGE | 606 | Q5T3J3 | |
| NMKSYEEYKLVVDGG | 66 | Q4VC12 | |
| GKYVYVVTELMKGGE | 486 | P51812 | |
| KDKIYMYGGKIDSTG | 401 | O75882 | |
| SYDKMVISLKGGEIY | 331 | Q10570 | |
| KCDYMDEVTYGELEK | 601 | Q1KMD3 | |
| LKAKYESDMVTGGYA | 701 | P42704 | |
| MGTEKEEQGKVYVYA | 516 | P56199 | |
| TIYMGKDKYENEDLI | 16 | Q86WR0 | |
| LKEVDELLYTYKEGM | 891 | A4FU69 | |
| YMGVIAEEEAYKSEL | 731 | Q13315 | |
| LQTMEEKKGISGYSY | 446 | Q8WYA0 | |
| EEADMYESKYGEVSK | 391 | Q8NA47 | |
| GVKIDKTDYMVGSYG | 136 | P52565 | |
| TDGKIEFISTMEGYK | 221 | Q92820 | |
| ETYVQDRGDGMYKVE | 1306 | P21333 | |
| YILEMEEETSGYGFK | 501 | Q9Y2H6 | |
| QKYLEVGRTMKEYED | 606 | Q8IVF4 | |
| GMIYKYIEYQGAEKE | 711 | Q9UHW9 | |
| SSDGMYEYGSIEKVK | 261 | Q9UMX9 | |
| VFELKETLMGKYGED | 96 | P12081 | |
| ETLMGKYGEDSKLIY | 101 | P12081 | |
| KTKEYKIVGMYSDGI | 196 | P43005 | |
| KKRGEKEETEYEYSG | 311 | Q8N4C8 | |
| EKYGEDSGLMYDLKD | 106 | P49590 | |
| NKGKVYDMELGEEFY | 1636 | Q9P212 | |
| EGEVKAKYTAQMYEL | 316 | P53041 | |
| TNDDKYVIDGKMYEL | 621 | Q9NRY4 | |
| GMIYKYIEYQGAEKE | 646 | Q9UP95 | |
| DYEKAMKEYEGGRGE | 606 | Q08945 | |
| IGKMTITEQKYEGEY | 251 | P28288 | |
| MEDYTKIEKIGEGTY | 1 | P06493 | |
| YEGKKIMADSGPIYD | 1126 | P07996 | |
| KSFVDYGDTVMYGLE | 111 | Q7Z2H8 | |
| EYIGEMGKDYIYAVT | 1156 | O75533 | |
| VMYGKVYRIEGDETS | 91 | P52434 | |
| LSKAVGYLTGDMKEY | 91 | Q15849 | |
| YEMYVSILKEGGKEL | 981 | Q9NYI0 | |
| SKYIGEYVDGRMEGK | 6 | Q5VZ52 | |
| KVSCTYKEDEGLYMV | 331 | Q5VTT5 |